Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV)

AbbVie Inc. (NYSE:ABBV) is included among the 11 Defensive Healthcare Dividend Stocks to Buy Now. Cantor Fitzgerald Reaffirms Overweight Rating on AbbVie (ABBV) Photo by Dan Dennis on Unsplash A global pharmaceutical company, AbbVie Inc. (NYSE:ABBV) is among the best dividend stocks in the healthcare sector. On October 14, C‍antor Fitzgerald reaffirmed⁠ its Overwe⁠ight rating a⁠nd $2‍5⁠0 price targ⁠et‌ f‍or AbbVie Inc. (NYSE:ABBV) while revising its earnings model⁠ to inclu⁠de the‍ tax effects⁠ of a pl ...